Primary Site >> Colorectal Cancer
Gene >> EGLN2
| 1. | |||||||||||
| Journal: | Cancer Res. 2003 Dec 15;63(24):8777-83. | ||||||||||
| Title: | Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth. | ||||||||||
| Author: | Erez, Neta|Milyavsky, Michael|Eilam, Raya|Shats, Igor|Goldfinger, Naomi|Rotter, Varda | ||||||||||
| PMID: | 14695194 | ||||||||||
| 2. | |||||||||||
| Journal: | Gastroenterology. 2010 Feb;138(2):606-15. | ||||||||||
| Title: | Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. | ||||||||||
| Author: | Xue, Jing|Li, Xuebing|Jiao, Shi|Wei, Ye|Wu, Guohao|Fang, Jing | ||||||||||
| PMID: | 19786027 | ||||||||||
| 3. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2011 Jun 3;409(2):315-20. | ||||||||||
| Title: | Prolyl hydroxylase domain protein 3 targets Pax2 for destruction. | ||||||||||
| Author: | Yan, Bing|Jiao, Shi|Zhang, Hai-sheng|Lv, Dan-dan|Xue, Jing|Fan, Li|Wu, Guo-hao|Fang, Jing | ||||||||||
| PMID: | 21575608 | ||||||||||
| 4. | |||||||||||
| Journal: | Exp Biol Med (Maywood). 2012 Jul;237(7):860-6. | ||||||||||
| Title: | Low expression of prolyl hydroxylase 2 is associated with tumor grade and poor prognosis in patients with colorectal cancer. | ||||||||||
| Author: | Xie, Ganfeng|Zheng, Lei|Ou, Juanjuan|Huang, Haihui|He, Jinxia|Li, Jianjun|Pan, Feng|Liang, Houjie | ||||||||||
| PMID: | 22802519 | ||||||||||
| 5. | |||||||||||
| Journal: | BMC Cancer. 2013 Nov 6;13:526. | ||||||||||
| Title: | Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer. | ||||||||||
| Author: | Rawluszko, Agnieszka A|Bujnicka, Katarzyna E|Horbacka, Karolina|Krokowicz, Piotr|Jagodzinski, Pawel P | ||||||||||
| PMID: | 24195777 | ||||||||||
| 6. | |||||||||||
| Journal: | EMBO Mol Med. 2015 Oct;7(10):1350-65. | ||||||||||
| Title: | PHD1 regulates p53-mediated colorectal cancer chemoresistance. | ||||||||||
| Author: | Deschoemaeker, Sofie|Di Conza, Giusy|Lilla, Sergio|Martin-Perez, Rosa|Mennerich, Daniela|Boon, Lise|Hendrikx, Stefanie|Maddocks, Oliver D K|Marx, Christian|Radhakrishnan, Praveen|Prenen, Hans|Schneider, Martin|Myllyharju, Johanna|Kietzmann, Thomas|Vousden | ||||||||||
| PMID: | 26290450 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Res. 2016 Apr 15;76(8):2219-30. | ||||||||||
| Title: | Prolyl Hydroxylase 3 Attenuates MCL-1-Mediated ATP Production to Suppress the Metastatic Potential of Colorectal Cancer Cells. | ||||||||||
| Author: | Radhakrishnan, Praveenkumar|Ruh, Nadine|Harnoss, Jonathan M|Kiss, Judit|Mollenhauer, Martin|Scherr, Anna-Lena|Platzer, Lisa K|Schmidt, Thomas|Podar, Klaus|Opferman, Joseph T|Weitz, Juergen|Schulze-Bergkamen, Henning|Koehler, Bruno C|Ulrich, Alexis|Schneid | ||||||||||
| PMID: | 26921340 | ||||||||||
| 8. | |||||||||||
| Journal: | Int J Biol Markers. 2017 Jul 24;32(3):e274-e277. | ||||||||||
| Title: | An insertion/deletion polymorphism within the promoter of EGLN2 is associated with susceptibility to colorectal cancer. | ||||||||||
| Author: | Li, Chaoyang|Feng, Lanjun|Niu, Luwei|Teng Li, Teng|Zhang, Bin|Wan, Huiping|Zhu, Zhansheng|Liu, Hao|Wang, Kai|Fu, Haixiao|Fu, Wei | ||||||||||
| PMID: | 28218358 | ||||||||||
| 9. | |||||||||||
| Journal: | Acta Biochim Biophys Sin (Shanghai). 2018 Jun 1;50(6):540-546. | ||||||||||
| Title: | Prolyl hydroxylase 2 is dispensable for homeostasis of intestinal epithelium in mice. | ||||||||||
| Author: | Xie, Yinghui|Yuan, Tanglong|Qin, Yanqing|Weng, Zhonghui|Fang, Jing | ||||||||||
| PMID: | 29688249 | ||||||||||